3-tritylthio-l-alanine has been researched along with ispinesib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Good, JA; Kaan, HY; Kozielski, F; Mackay, SP; Rath, O; Sutcliffe, OB; Wang, F | 1 |
| Good, JA; Kaan, HY; Kozielski, F; MacKay, SP; Podgórski, D; Rath, O; Talapatra, SK; Wang, F | 1 |
| Asai, A; Hashimoto, A; Ishikawa, Y; Matsuno, K; Ogo, N; Sawada, J | 1 |
3 other study(ies) available for 3-tritylthio-l-alanine and ispinesib
| Article | Year |
|---|---|
Triphenylbutanamines: kinesin spindle protein inhibitors with in vivo antitumor activity.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzene Derivatives; Biological Availability; Butylamines; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Kinesins; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasm Transplantation; Protein Binding; Protein Conformation; Quinazolines; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous | 2012 |
Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models.
Topics: Animals; Antineoplastic Agents; Benzamides; Butylamines; Cell Line, Tumor; Chromones; Cysteine; Kinesins; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Quinazolines; Structure-Activity Relationship; Transplantation, Heterologous | 2013 |
Structure-Guided Design of Novel l-Cysteine Derivatives as Potent KSP Inhibitors.
Topics: | 2015 |